360° SearchNetwork Hot Spots Trends Time Series

tumor necrosis factor

Type: Keyphrase

Name: tumor necrosis factor

First reported 20 hours ago - Updated 20 hours ago - 1 reports

Methotrexate Failures in RA, Ustekinumab Success in PsA, and Mood-Immunity Links

, online first. Full text $15N Engl J Med, June 11, 2013, online first. Full text $15Triple therapy was noninferior to methotrexate plus etanercept for rheumatoid arthritis (RA) patients with inadequate response to methotrexate monotherapy. The improvement ... [Published Consultant Live - 20 hours ago]

Entities: Ustekinumab, Methotrexate, Patient, Placebo, Enbrel

First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

Harvard School of Public Health

Studies from Harvard School of Public Health in the Area of Clinical Trials and Studies Reported

(NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- Data detailed on Research have been presented. According to news reporting from Boston, Massachusetts, by NewsRx journalists, research stated, "Chronic inflammation may mediate risk of ... [Published NewsRX - Jun 14 2013]

Entities: Harvard School of Public Health, Clinical trials, interleukin-6, tumor necrosis factor

First reported Jun 09 2013 - Updated Jun 09 2013 - 1 reports

McMaster University

Study of mice suggests babies with Tay-Sachs relief

Tay-Sachs disease, the degenerative and always fatal neurological genetic disease that is most commonly carried by Ashkenazi Jews, has been recognized even by ultra-Orthodox rabbis as a legitimate reason for the abortion of an affected fetus. But readily ... [Published Big News Network - Jun 09 2013]

Entities: Tay-Sachs Disease, Ashkenazi Jews, tumor necrosis factor, McMaster University, Genetic Disorder

First reported Jun 07 2013 - Updated Jun 07 2013 - 1 reports

AbbVie Jumps Into $11.4M Series B For Avaxia Biologics

Avaxia Biologicsâs big plan has been to create a line of drugs that go after the same protein, tumor necrosis factor, that AbbVieâs adalimumab (Humira) does?just in a different, more localized way. Clearly, its approach has gotten AbbVieâs (NYSE: ABBV) ... [Published Xconomy - Jun 07 2013]

Entities: AbbVie, Drugs, Biologics, Antibody, Adalimumab

First reported Jun 07 2013 - Updated Jun 07 2013 - 1 reports

Enbrel

Findings from L.N. Liu and Co-Researchers Provides New Data on Arthritis

(NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- New research on Joint Diseases and Conditions is the subject of a report. According to news reporting out of Baltimore, Maryland, by NewsRx editors, research stated, "Rheumatoid ... [Published NewsRX - Jun 07 2013]

Entities: Arthritis, tumor necrosis factor, fusion protein, Enbrel

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy

by Frederikke F. Rönsholt, Henrik Ullum, Terese L. Katzenstein, Jan Gerstoft, Sisse R. OstrowskiObjectiveThe study investigated markers of inflammation and endothelial activation in HIV infected patients after 12 years of successful combination antiretroviral ... [Published Elites TV - Jun 04 2013]

Entities: Inflammation, antiretroviral therapy, Patient

First reported Jun 01 2013 - Updated Jun 01 2013 - 1 reports

Adalimumab

Only one-fifth of RA patients had overall adherence rate to prescribed oral medications study finds

Only one-fifth of RA patients had overall adherence rate to prescribed oral medications, study finds DMARDs ) were correctly followed by RA patients. According to ACR estimates, more than one million U.S. adults experience inflammation, pain, tenderness ... [Published Big News Network - Jun 01 2013]

Entities: Patient, Adalimumab, tumor necrosis factor

First reported May 31 2013 - Updated May 31 2013 - 1 reports

New Findings on Proteomics from University of Miami Miller School of Medicine Summarized

(NewsRx) -- By a News Reporter-Staff News Editor at Proteomics Weekly -- Fresh data on Proteomics are presented in a new report. According to news reporting originating in Miami, Florida, by NewsRx journalists, research stated, "Objective Evaluate the ... [Published NewsRX - May 31 2013]

Entities: Proteomics, University of Miami Miller School of Medicine, Organ of Corti

First reported May 31 2013 - Updated May 31 2013 - 1 reports

Data on Inflammation Described by Researchers at University College London

(NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Inflammation have been presented. According to news reporting from London, United Kingdom, by NewsRx editors, the research stated, "The discovery of tumor necrosis factor ... [Published NewsRX - May 31 2013]

Entities: University College London, Inflammation, tumor necrosis factor, Cancer, Drugs

First reported May 30 2013 - Updated May 30 2013 - 1 reports

Rheumatoid arthritis patients not taking their medications as prescribed

A new study conducted in an ethnically diverse and predominantly low income population found that only one-fifth of rheumatoid arthritis (RA) patients had an overall adherence rate to prescribed oral medications at 80% or greater. Findings published today ... [Published Bio-Medicine - May 30 2013]

Entities: Rheumatoid Arthritis, Patient, Methotrexate, infliximab, Enbrel

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Recent Reports from Harbin Medical University Highlight Findings in Tumor Necrosis Factor Decoy Receptors

(NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Data detailed on Immunology have been presented. According to news reporting originating from Harbin, People's Republic of China, by NewsRx correspondents, research stated, "The ... [Published NewsRX - May 24 2013]

Entities: Harbin, tumor necrosis factor, Trace Element, Calcium, Decoy

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Findings on Colon Cancer Detailed by Researchers at University of California

(NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Colon Cancer have been presented. According to news reporting originating from La Jolla, California, by NewsRx correspondents, research stated, "Tumor necrosis factor ... [Published NewsRX - May 24 2013]

Entities: Colorectal Cancer, University of California, Tumor, Carcinogenesis, tumor necrosis factor

Quotes

...4 times more anti-TNF therapy, than normal weight to achieve the outcomes," the researchers wrote in their report. "BMI is one of the few modifiable variables influencing the major outcomes in rheumatoid arthritis."

The Weight on the Joints [Published Daily Rx - 3 hours ago]

She said that "the line of demarcation Yeda has drawn is more illusory than real. Counsel for Yeda acknowledged at oral argument that, in a nutshell, Dr. Engelmann's expert testimony will be that the protocols Yeda performed in 1989 as a prelude to its 339 Application are divergent from the protocols described in Abbott's 072 Application. ... Moreover, Dr. Engelmann himself acknowledged reading at least his own 2003 report in preparation for his fact deposition in this case, further demonstrating that the overlap in subject matter is sufficient to justify granting Abbott's motion to compel."

Quarter-Century Patent War Crawls Toward Trial [Published Courthouse News Service - 16 hours ago]

"Patients with pre-existing damage demonstrated significant increases in the ARASHI change score during two-years of TNF-blocking therapy; highlighting progressive destruction even under drug therapy. These data show that joints are best protected with early and accurate evaluation, to ensure they do not exceed an ARASHI score of two, prior to the start of drug treatment" said Matsushita

Joint Damage Successfully Recognized in Rheumatoid Arthritis [Published Health Imaging Hub - Jun 18 2013]

"We will continue to execute on our partnering strategy and to bring in more late-stage programmes and products already approved outside of China, to complement our R&D pipeline and strengthen our in-market portfolio" he added

BMS partners with Simcere to market arthritis drug Orencia SC in China [Published PMLive - Jun 17 2013]

More Content

sort by: Date \| Relevance
The Weight on the Joints [Published Daily Rx - 3 hours ago]
p75 Neurotrophin Receptor Is a Clock Gene That ... [Published Journal of Neuroscience - 14 hours ago]
Quarter-Century Patent War Crawls Toward Trial [Published Courthouse News Service - 16 hours ago]
Methotrexate Failures in RA, Ustekinumab Succes... [Published Consultant Live - 20 hours ago]
Exercise After Cancer Diagnosis: Time to Get Mo... [Published Cancernetwork.com - Jun 19 2013]
Enbrel and the Autoimmune Era [Published Yahoo! Finance - Jun 18 2013]
Joint Damage Successfully Recognized in Rheumat... [Published Health Imaging Hub - Jun 18 2013]
BMS partners with Simcere to market arthritis d... [Published PMLive - Jun 17 2013]
Daily Cleanse colon liver blood [Published Global FoodMate - Jun 17 2013]
Anti-TNF Doses Can Be Cut in Spinal Arthritis [Published MedPage Today - Jun 15 2013]
Remission Rates are Lower in Obese and Overweig... [Published MedIndia - Jun 15 2013]
New Data on UCB's Cimzia - Analyst Blog [Published Nasdaq - Jun 14 2013]
New Data on UCB's Cimzia - Analyst Blog [Published Quote.com Canada - Jun 14 2013]
Many Stop Taking Rheumatoid Arthritis Meds Too ... [Published Health.com - Jun 14 2013]
New Data on UCB's Cimzia [Published Yahoo! Finance - Jun 14 2013]
Studies from Harvard School of Public Health in... [Published NewsRX - Jun 14 2013]
Rheumatoid arthritis patients not taking their ... [Published NewsRX - Jun 14 2013]
New Market Research Report: Neovacs SA (ALNEV) ... [Published Live-PR.com - Jun 14 2013]
Triple Therapy Matches Biologic in RA [Published MedPage Today - Jun 14 2013]
TRAF molecules in cell signaling and in human d... [Published 7thSpace - Jun 13 2013]
50 percent of rheumatoid arthritis patients dis... [Published EurekAlert! - Jun 13 2013]
B-MS' Orencia equal to Humira in head-to-head R... [Published Pharma Times - Jun 13 2013]
Stelara Succeeds in Psoriatic Arthritis [Published MedPage Today - Jun 12 2013]
BMS' Orencia matches Humira in arthritis study [Published PMLive - Jun 12 2013]
ORENCIA® (abatacept) Shows Comparable Efficacy ... [Published Yahoo! Finance - Jun 11 2013]
Pfizer and Takeda launch Enbrel injection for r... [Published Labmate Online - Jun 10 2013]
Pfizer Japan and Takeda Launch "EnbrelÂ® Subcut... [Published Individual.com - Jun 10 2013]
Insulin resistance linked to asthma in postmeno... [Published MedWire News - Jun 10 2013]
Pfizer Japan and Takeda Launch "Enbrel$ Subcuta... [Published Noodls - Jun 10 2013]
Study of mice suggests babies with Tay-Sachs re... [Published Big News Network - Jun 09 2013]

Blogs

sort by: Date \| Relevance
Weekly Roundup 5-17-13 [Published Eye on FDA - May 17 2013] It has been a busy May. From working in the yard to transform it from looking like property on which Boo Radley might have a house to putting on panel discussions and layers of business travel to grading papers and posting final grades to end up ...
4 Healthcare Stock Stories Prescribed for Inves... [Published Wall St. Cheat Sheet - May 15 2013] Boston Scientific Corporation ( NYSE:BSX ): Closing price $9.12 The initial patient has been enrolled in a clinical investigation studying the use of the company’s WallFlex Biliary RX Stent, which is a self-expanding metal stent, as a bridge to surgery ...
Tumefactive demyelinating lesions during etaner... [Published Multiple Sclerosis Journal recent issues - May 08 2013] Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory and immunoregulatory cytokine involved in the pathogenesis of several autoimmune disorders. Etanercept, a TNF-α antagonist (anti-TNF-α) acting as a soluble TNF-α receptor, has been associated ...
Enbrel for Stroke and Alzheimer’s [Published Science-Based Medicine - May 08 2013] A recent article in the LA times tells of a husband’s quest to find a treatment for his wife’s Alzheimer’s disease. This is a narrative that journalists know and love – the brave patient or loved-one who won’t accept the nihilism of the medical establishment, ...
Training in MS: influence of two different endu... [Published Multiple Sclerosis Journal recent issues - Apr 18 2013] Background: The influences of exercising on cytokine response, fatigue and cardiorespiratory values are important aspects of rehabilitation in persons with multiple sclerosis (PwMS). Exercise performed within these programs is often practised in water ...

Press Releases

sort by: Date \| Relevance
Research and Markets: Competitor Analysis: TNF ... [Published Business Wire Science: Science News - Mar 28 2013]
Research and Markets: Competitor Analysis: TNF ... [Published Business Wire Health News - Mar 28 2013]